Insulin human (rDNA origin, Novo Nordisk)
人胰岛素（诺和诺德）
Report date: 2026/05/26 20:00:28
Base Information
Drug NameInsulin human (rDNA origin, Novo Nordisk)
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1991/06/25
Country/Territory +[19]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk IncHealthpartners InstituteNovo Nordisk A/S +[4]
Inactive CompaniesWashington University School Of MedicineMedical University Of GrazUniversity Of Washington +[4]
Active Indications +[5]
Inactive Indications +[7]